Stocks · Healthcare · Medical - Diagnostics & Research
IQVIA Holdings Inc. IQV
$266.09 +3.05% Close, Oct 5, 2026 · NYSE · Market cap $42.50B
Strong trend
Next earnings report: Oct 27, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Earnings beat analyst estimates in each of the last 14 quarters (average surprise over the last four: +2.0%).
- Net debt is 4.1× EBITDA, a high level of leverage.
- The stock is in an uptrend: above its 200-day average for 67 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 48%
- EPS growth (TTM, YoY)Top 43%
- FCF growth (TTM, YoY)Top 39%
- Revenue growth, 3-year CAGRBottom 35%
- Revenue growth accelerationTop 37%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 18%
- Gross marginBottom 17%
- Operating marginTop 19%
- Cash conversion (OCF / net income)Top 30%
- Accruals (lower is better)Bottom 42%
- Net debt / EBITDA (lower is better)Bottom 20%
- Interest coverTop 33%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 17%
- Free-cash-flow yieldTop 14%
- EBITDA / enterprise valueTop 19%
- Sales / enterprise valueTop 43%
- P/E vs own 5-year history (lower is better)Bottom 37%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 41%
- 6-month returnTop 18%
- 1-year return vs S&P 500Top 37%
- Distance from 52-week highTop 8%
- Trend checklist (0–4)Top 26%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 46%
- Consecutive EPS beatsTop 2%
- Share of analysts rating BuyTop 40%
- Upside to consensus price targetBottom 11%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 20%
- Maximum drawdown, 3 yearsTop 20%
- Beta vs S&P 500 (lower is better)Top 38%
- Net debt / EBITDA (lower is better)Bottom 20%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 7.3% | 8.2% | ↑ |
| EPS growth (YoY) | 9.9% | 16.6% | ↑ |
| Gross margin | 34.2% | 26.2% | ↓ |
| Operating margin | 13.9% | 13.6% | ↓ |
| FCF margin | 12.8% | 15.4% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 8.2% | 7.3% | ↑ | Bottom 48% |
| EPS growth (TTM, YoY) | 16.6% | 9.9% | ↑ | Top 43% |
| Gross margin | 26.2% | 34.2% | ↓ | Bottom 17% |
| Operating margin | 13.6% | 13.9% | ↓ | Top 19% |
| Net margin | 8.1% | 7.9% | ↑ | — |
| Free-cash-flow margin | 15.4% | 12.8% | ↑ | — |
| Return on invested capital | 8.3% | — | Top 18% | |
| Revenue growth, 3-year CAGR | 4.2% | — | Bottom 35% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 2.05×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -8.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 4.06×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 3.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.56%
- Shareholder yield
- 0.56%
- Share count change, 1 year
- -2.7%
- Share count change, 3-year CAGR
- -3.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 28, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 14
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +2.0%
- Average 2-day reaction, last 8
- +3.1%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $264.30
- Target vs current price
- -0.7%
- Analysts with a rating
- 45
- Share rating Buy or Strong Buy
- 82%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 28, 2026 | +4.0% | +13.9% | +9.4% | +22.1% | — |
| May 5, 2026 | +2.8% | +9.6% | +7.8% | +12.2% | +47.8% |
| Feb 5, 2026 | +0.6% | -10.7% | -12.5% | -11.9% | -22.1% |
| Oct 28, 2025 | +0.7% | +0.3% | -1.6% | +4.9% | +8.2% |
| Jul 22, 2025 | +1.4% | +17.9% | +24.4% | +21.1% | +28.8% |
| May 6, 2025 | +2.7% | -4.0% | +2.5% | -6.3% | +22.0% |
| Feb 6, 2025 | +0.3% | +2.2% | -3.7% | -9.7% | -25.3% |
| Oct 31, 2024 | +0.7% | -4.7% | +2.4% | -6.8% | -8.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 28, 2026 | $3.15 | $3.03 | +4.0% | $4.37B |
| May 5, 2026 | $2.90 | $2.82 | +2.8% | $4.15B |
| Feb 5, 2026 | $3.42 | $3.40 | +0.6% | $4.36B |
| Oct 28, 2025 | $3.00 | $2.98 | +0.7% | $4.10B |
| Jul 22, 2025 | $2.81 | $2.77 | +1.4% | $4.02B |
| May 6, 2025 | $2.70 | $2.63 | +2.7% | $3.83B |
| Feb 6, 2025 | $3.12 | $3.11 | +0.3% | $3.96B |
| Oct 31, 2024 | $2.84 | $2.82 | +0.7% | $3.90B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 33.0× | 31.9× | 57th | Top 17% |
| P/E (forward) | 20.5× | — | — | — |
| EV / EBITDA | 16.1× | — | — | Top 19% |
| EV / Sales | 3.35× | — | — | Top 43% |
| Free-cash-flow yield | 6.15% | — | — | Top 14% |
| Earnings yield | 3.03% | — | — | Top 17% |
P/E over the past five years
Range 19.9× – 78.4× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +30.2%
- Earnings per share growth (TTM)
- +16.6%
- Change in P/E multiple
- +11.1%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 72
- Days above the 200-day average
- 67
- 50-day average slope (20 days)
- +10.8%
- 200-day average slope (20 days)
- +2.1%
- Distance from 50-day average
- +4.4%
- Distance from 200-day average
- +29.1%
- RSI (14)
- 53.9
- Relative volume
- 1.01×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 38.6%
- Volatility vs own 5-year history
- 70th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.92
- Correlation with S&P 500
- 0.32
- Current drawdown from 1-year high
- -3.2%
- Maximum drawdown, 3 years
- -47.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 30, 2021 | May 23, 2025 | -51.5% | 852 days | Not yet recovered |
| Oct 20, 2020 | Oct 30, 2020 | -11.2% | 8 days | 6 days (Nov 9, 2020) |
| Sep 2, 2021 | Oct 12, 2021 | -10.1% | 27 days | 25 days (Nov 16, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $42.50B
- P/E (TTM)
- 33.0
- EPS, diluted (TTM)
- $8.06
- Revenue (TTM)
- $16.98B
- 52-week range
- $154.50 – $277.40
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $13.87B | $14.41B | $14.98B | $15.40B | $16.31B |
| Gross profit | $4.64B | $5.03B | $5.24B | $5.38B | $4.29B |
| Operating income | $1.39B | $1.80B | $1.98B | $2.20B | $2.29B |
| Net income | $966.0M | $1.09B | $1.36B | $1.37B | $1.36B |
| EPS (diluted) | $4.95 | $5.72 | $7.29 | $7.49 | $7.84 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.90B | $3.96B | $3.83B | $4.02B | $4.10B | $4.36B | $4.15B | $4.37B |
| Net income | $285.0M | $437.0M | $249.0M | $266.0M | $331.0M | $514.0M | $274.0M | $256.0M |
| EPS (diluted) | $1.55 | $2.42 | $1.40 | $1.54 | $1.93 | $2.99 | $1.61 | $1.53 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $2.94B | $2.26B | $2.15B | $2.72B | $2.65B |
| Capital expenditure | -$640.0M | -$674.0M | -$649.0M | -$602.0M | -$603.0M |
| Free cash flow | $2.30B | $1.59B | $1.50B | $2.11B | $2.05B |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$406.0M | -$1.17B | -$992.0M | -$1.35B | -$1.31B |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $2.08B
- Total assets
- $29.88B
- Total liabilities
- $23.58B
- Total debt
- $16.24B
- Net debt
- $14.33B
- Shareholders’ equity
- $6.17B
As of Jun 30, 2026 (filed Jul 28, 2026).
Short interest
- Shares sold short
- 4,116,522
- Days to cover
- 3.05
- Change vs previous report
- +9.0%
FINRA short interest, settlement date Sep 15, 2026.